ConductScience.org, home
Genes
API referenceFor AI assistants

Gene · 407009

MIR224: microRNA 224

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR224: microRNA 224. Genes, record 407009. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/407009

On this page

Gene

Symbol
MIR224
HGNC
Name
microRNA 224
HGNC
NCBI Gene ID
407009
NCBI Gene
HGNC ID
HGNC:31604
HGNC
Ensembl
ENSG00000284363
NCBI Gene
Aliases
MIRN224, hsa-mir-224, miRNA224
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants710

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR224 papersNewest fiscal year
P30CA016058Cancer Center Support Grant42025
P30CA008748Cancer Center Support Grant32025
P30CA016672Cancer Center Support Grant32025
P30DK042086Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID)32025
T32HL098129Training Program in Cardiometabolic Diseases32025
P01HL116263HDL Function in Human Disease22025
P20GM103436IDeA Networks of Biomedical Research Excellence in Kentucky22025
P20GM103446Delaware INBRE22025
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant22025
P30CA015704Cancer Center Support Grant22025

1 to 10 of 710Source NIH's project files

See all 710 nih grants

Papers2,564

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
MicroRNA-phytochemical interactome targeting thioredoxin-interacting protein: a narrative review at the nexus of RNA therapeutics, cancer biology, and metabolic regulation.Front Oncol202642712981PubTator, text miningPubMed
MicroRNA-224 orchestrates BMP and TGFβ signaling and is a therapeutic target in preclinical pulmonary arterial hypertension.Sci Transl Med202642685153PubTator, text miningPubMed
Exploratory analysis of circulating miRNA-100 and its association with eosinophilia in pediatric allergic rhinitis.Otolaryngol Pol202642578832PubTator, text miningPubMed
Near-infrared/glutathione-activated CRISPR/Cas13a sensing platform for the detection of multiple microRNAs.RSC Adv202642395760PubTator, text miningPubMed
Silent Messengers: The Role of Extracellular Vesicle-Associated miRNAs in the Non-Invasive Profiling of Hepatocellular Carcinoma.Biomedicines202642351746PubTator, text miningPubMed
Can alterations in miR-21, miR-1, and miR-224 expression predict personalized medicine chemotherapy in non-small cell lung cancer?Mol Biol Rep202642268452PubTator, text miningPubMed
miR-221/222, miR-224, and miR-339 are Overexpressed as Potential Biomarkers in Follicular Thyroid Neoplasms.Indian J Surg Oncol202642221262PubTator, text miningPubMed
ANKFN1 in skin fibroblasts may modulate mast cell activity and is associated with dupilumab response in atopic dermatitis.Immunol Res202642062651PubTator, text miningPubMed
Multifunctional double hairpin DNA polydopamine nano-system for "switch-on" detection and intervention of high-grade dysplastic nodules.Mikrochim Acta202642053823PubTator, text miningPubMed
Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma.Med Sci (Basel)202641892825PubTator, text miningPubMed

1 to 10 of 2,564

See all 2,564 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/407009

GET https://conductscience.org/api/genes/v1/407009/grants?page=2

API referenceFor AI assistants